Early Tricuspid Valve Surgery for Heart Failure in Congenital Heart Disease

Why This Problem Exists

In transposition of the great arteries, the right ventricle sometimes has to pump blood to the whole body 0:08. This is not a theoretical concern — it describes the actual anatomy in a subset of adults who had atrial switch operations (Mustard or Senning procedures) as infants, before the arterial switch became standard 0:08. The right ventricle was not built to pump blood to the whole body 0:08. It is a thin-walled chamber designed to push blood through the low-resistance pulmonary circuit, not sustain systemic pressures for decades 0:08. The question is not whether it will fail, but when, and what can be done to delay that 0:08.

The Core Clinical Problem

Over time, many patients with transposition of the great arteries develop severe tricuspid regurgitation and worsening heart function 0:16. The tricuspid valve sits between the right atrium and the systemic right ventricle 0:08. As the ventricle dilates under chronic pressure overload, the valve annulus stretches and the leaflets fail to coapt 0:16. Regurgitation begets further dilation, which worsens regurgitation — a cycle that accelerates ventricular dysfunction 0:16. The clinical question is whether intervening on the valve can interrupt this progression, and if so, when 0:25 0:33.

The Surgical Decision

The timing of tricuspid valve surgery in this population has been contested because the operation itself carries risk, and the systemic right ventricle may already be too compromised to benefit 0:25 0:33. A recent study examined outcomes based on the degree of ventricular dysfunction at the time of surgery 0:25. Patients with moderate to severe tricuspid valve leakage but only mild to moderate ventricular dysfunction had better outcomes after surgery 0:25. If the right ventricle was already severely weak, tricuspid valve surgery did not make a difference in outcomes 0:33.

This is a threshold effect, not a gradient 0:25 0:33. Once severe ventricular dysfunction is established, valve repair or replacement does not reverse the myocardial remodeling that has already occurred 0:33. The ventricle remains dilated, hypokinetic, and unable to sustain systemic output 0:33. The operation removes one hemodynamic insult — the regurgitant volume — but the muscle itself is spent 0:33. By contrast, intervening earlier, when the ventricle still has contractile reserve, allows it to recover geometry and function after the volume overload is corrected 0:25.

What This Means for Practice

In patients with transposition of the great arteries, earlier tricuspid valve surgery can improve outcomes 0:37. This shifts the risk calculus 0:25 0:37. The traditional approach has been to delay surgery until symptoms are severe or the ventricle is failing, on the grounds that any operation on a systemic right ventricle is high-risk and should be deferred as long as possible 0:25 0:33. The evidence now suggests the opposite: deferring surgery until the ventricle is severely dysfunctional forfeits the opportunity for benefit 0:33 0:37. The operation becomes futile rather than merely risky 0:33.

The practical implication is that moderate to severe tricuspid regurgitation in a patient with a systemic right ventricle and mild to moderate dysfunction is an indication for referral, not observation 0:25 0:37. These patients need serial imaging to track ventricular function and valve severity, and they need a relationship with a center that manages adult congenital heart disease 0:16 0:37. The window for intervention is narrow — bounded on one side by the risk of operating too early on a valve that is not yet severely regurgitant, and on the other by the irreversibility of severe ventricular dysfunction 0:25 0:33.

When to Involve This Team

Any adult with transposition of the great arteries and a systemic right ventricle should be followed in an adult congenital heart disease clinic, not in general cardiology 0:16 0:37. These patients require echocardiography at least annually, and more frequently if tricuspid regurgitation is moderate or greater 0:16. If imaging shows worsening regurgitation or declining ventricular function — even if the patient is asymptomatic — that is the time for surgical evaluation, not when heart failure symptoms appear 0:25 0:37. By the time a patient with a systemic right ventricle develops dyspnea or edema, the ventricle is often severely impaired and the opportunity for surgical benefit may have passed 0:33.

Referring clinicians should understand that "doing well" in this population is a temporary state 0:08 0:16. The systemic right ventricle is under continuous strain, and the trajectory is toward failure 0:08 0:16. The goal of early valve surgery is to slow that trajectory, not to cure the underlying problem 0:37. These patients will eventually need heart transplantation or mechanical support, but extending the time to that endpoint is a meaningful clinical win 0:37.

Why This Problem Exists

In certain congenital heart repairs—most notably the atrial switch operation for transposition of the great arteries—the right ventricle is left connected to the aorta 0:08. It becomes the systemic ventricle, pumping against systemic vascular resistance for the patient's entire life 0:08. The right ventricle was not built for this 0:08. Its architecture evolved to handle the low-pressure pulmonary circuit 0:08. Ask it to sustain systemic pressure for decades and it begins to fail 0:08. The tricuspid valve, which guards the inlet to this overworked chamber, often becomes regurgitant as the ventricle dilates 0:16. The question is when to intervene on that valve.

The Core Clinical Problem

Many of these patients develop severe tricuspid regurgitation and progressive ventricular dysfunction 0:16. The regurgitation worsens the volume load on an already stressed ventricle; the ventricular dysfunction worsens the regurgitation by distorting the valve annulus 0:16. It is a vicious cycle. The surgical question is whether repairing or replacing the tricuspid valve can interrupt that cycle—and if so, at what point in the disease trajectory.

The traditional approach has been to wait until symptoms are severe or ventricular function is clearly declining. The logic: surgery carries risk, and operating earlier means exposing patients to that risk before it is clearly necessary. But waiting has its own cost 0:33. If the ventricle deteriorates past a certain point, valve surgery may no longer help 0:33.

What This Study Found

The study examined outcomes after tricuspid valve surgery in adults with systemic right ventricles, stratified by the degree of ventricular dysfunction at the time of operation 0:25. Patients with moderate to severe tricuspid regurgitation but only mild to moderate ventricular dysfunction had better outcomes after surgery 0:25. If the right ventricle was already severely weak at the time of surgery, the operation did not improve outcomes 0:33.

This is a threshold effect 0:25 0:33. There appears to be a window during which valve surgery is beneficial—after regurgitation has become significant but before ventricular function has deteriorated irreversibly 0:25 0:33. Operate too early and you subject patients to unnecessary risk; operate too late and the ventricle cannot recover even after the volume load is corrected 0:33.

The Implication for Timing

The conclusion drawn from this evidence is that earlier tricuspid valve surgery can improve outcomes in this population 0:37. "Earlier" here means earlier in the trajectory of ventricular dysfunction—while dysfunction is still mild to moderate rather than severe 0:25 0:37. It does not mean operating on asymptomatic patients with normal ventricular function and trivial regurgitation.

This represents a shift from the traditional wait-and-see approach 0:37. The data suggest that by the time severe ventricular dysfunction is present, the opportunity for surgical benefit has passed 0:33. The implication is that surveillance should focus on detecting the transition from mild to moderate dysfunction 0:25, and that this transition—in the presence of significant regurgitation—should trigger consideration of surgery rather than further observation 0:37.

What Remains Uncertain

The discussion does not define the thresholds precisely. What ejection fraction separates mild from moderate dysfunction in a systemic right ventricle? What degree of regurgitation qualifies as "moderate to severe"? These are not trivial questions. Right ventricular function is harder to quantify than left ventricular function; standard echocardiographic measures perform poorly. Advanced imaging—cardiac MRI with strain analysis—is often required, and even then the cutoffs are not universally agreed upon.

The discussion also does not address which patients should undergo repair versus replacement, what operative techniques are preferred, or how outcomes vary by center volume. These are real-world variables that affect whether the theoretical benefit of earlier surgery translates into actual benefit for an individual patient.

When to Involve This Team

Adults with systemic right ventricles should be followed in specialized adult congenital heart disease centers 0:08. If you are managing one of these patients in a general cardiology practice, the threshold for referral is low. Any patient with more than mild tricuspid regurgitation or any decline in ventricular function—even if still in the mild-to-moderate range—warrants subspecialty evaluation 0:25 0:37. The window for beneficial intervention may be narrower than previously thought 0:33 0:37, and identifying that window requires expertise in imaging the systemic right ventricle and experience with the outcomes of surgery in this population.

If a patient presents with severe ventricular dysfunction and severe regurgitation, referral is still appropriate, but the discussion should include realistic expectations 0:33. The evidence suggests that surgery at this stage may not reverse the trajectory 0:33.